At today’s general meeting, Spolchemie’s shareholders approved the sale of the minority shareholders’ shares to the majority owner of Spolchemie, the KAPRAIN investment group. The latter has thus taken the final step towards acquiring a 100% stake in the chemical company. The minority shareholders will sell their shares for CZK 451. This price was determined by an expert opinion.

The Spartan Blood project is among the winners at the 2025 Giving Tuesday Awards
The Spartan Blood charity project, which we got involved with through the Kaprain Endowment Fund, is collecting one award after
